Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 22, Issue 5, 2000, Pages 773-780

  Gage, Richard ^a   Venn, Richard F ^a   Bayliss, Mark A J ^a   Edgington, Alan M ^a   Roffey, Sarah J ^a   Sorrell, Brian ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Analysis; Fluorescence detection; Human plasma; Inclusion complex; Size exclusion chromatography; Sulphobutylether cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE;

ACCURACY; ADULT; ARTICLE; CALIBRATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TECHNIQUE;

BETA-CYCLODEXTRINS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; ETHERS; HUMANS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE;

EID: 0034214273     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00283-6     Document Type: Article

References (20)

1. Szejtli J. Chem. Rev. 98:1998;1743-1753.
2. Loftsson T., Brewster M. J. Pharm. Sci. 85(10):1996;1017-1025.
3. Rajewski R., Stella V.J. J. Pharm. Sci. 85(11):1996;1142-1169.
4. Uekama K., Hirayama F., Irie T. Chem. Rev. 98:1998;2045-2076.
5. Szejtli J. Med. Res. Rev. 14(3):1994;353-386.
6. Brook S., Swift R., Harrigan E.P., Tensfeldt T. Psychopharmacol. Bull. 33(3):1997;498.
7. Bresolle F., Audran M., Pham T., Vallon J. J. Chromatogr. B. 687:1996;303-336.
8. Han S.M. Biomed. Chromatogr. 11(5):1997;259-271.
9. Kubota Y., Fukuda M., Ohtsuji K., Koizumi K. Anal. Biochem. 201:1992;99-102.
10. Haginaka J., Nishimura Y., Yasuda H. J. Pharm. Biomed. Anal. 11(10):1993;1023-1026.
11. Koizumi K., Kubota Y., Okada Y., Utamura T. J. Chromatogr. B. 341:1985;31-41.
12. Blum W., Aichholz R., Ramstein P., Fetz A., Raschdorf F. J. Chromatogr. B. 720:1998;171-178.
13. Frankewich R.P., Thimmaiah K.N., Hinze W.L. Anal. Chem. 63:1991;2924-2933.
14. Grosse P.Y., Pinguet F., Joulia J.M., Astre C., Bressole F. J. Chromatogr. B. 694:1997;219-226.
15. Reeuwijk H.J.E.M., Irth H., Tjaden U.R., Merkus F.W.H.M., van der Greef J. J. Chromatogr. B. 614:1993;95-101.
16. S. Roffey, Department of Drug Metabolism, Pfizer Central Research, Sandwich, Kent, Internal Report.
17. Zia V., Rajewski R., Bornancini E.R., Luna E.A., Stella V.J. J. Pharm. Sci. 86(2):1997;220-224.
18. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layoff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309-312.
19. Dadgar D., Burnett P.E., Choc M.G., Gallicano K., Hooper J.W. J. Pharm. Biomed. Anal. 13(3):1995;89-97.
20. Bressolle F., Bromet-Petit M., Audran M. J. Chromatogr. B. 686:1996;3-10.